nodes	percent_of_prediction	percent_of_DWPC	metapath
Mitoxantrone—SLC47A2—renal system—rectum cancer	0.0535	0.0686	CbGeAlD
Mitoxantrone—PIM1—seminal vesicle—rectum cancer	0.0434	0.0556	CbGeAlD
Mitoxantrone—SLC47A2—vagina—rectum cancer	0.0387	0.0497	CbGeAlD
Mitoxantrone—BTK—mammalian vulva—rectum cancer	0.0377	0.0484	CbGeAlD
Mitoxantrone—PIM1—renal system—rectum cancer	0.0349	0.0448	CbGeAlD
Mitoxantrone—PIM1—urethra—rectum cancer	0.0343	0.044	CbGeAlD
Mitoxantrone—SLC47A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC14A2—rectum cancer	0.0334	0.152	CbGpPWpGaD
Mitoxantrone—PIM1—mammalian vulva—rectum cancer	0.0327	0.0419	CbGeAlD
Mitoxantrone—BTK—vagina—rectum cancer	0.0292	0.0374	CbGeAlD
Mitoxantrone—PIM1—female reproductive system—rectum cancer	0.028	0.0359	CbGeAlD
Mitoxantrone—PIM1—vagina—rectum cancer	0.0253	0.0324	CbGeAlD
Mitoxantrone—SLC47A1—seminal vesicle—rectum cancer	0.0232	0.0298	CbGeAlD
Mitoxantrone—SLC47A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC14A2—rectum cancer	0.0215	0.0978	CbGpPWpGaD
Mitoxantrone—TOP2A—mammalian vulva—rectum cancer	0.0192	0.0246	CbGeAlD
Mitoxantrone—BTK—lymph node—rectum cancer	0.0189	0.0242	CbGeAlD
Mitoxantrone—SLC47A1—renal system—rectum cancer	0.0187	0.024	CbGeAlD
Mitoxantrone—SLC47A1—urethra—rectum cancer	0.0184	0.0236	CbGeAlD
Mitoxantrone—SLC47A1—mammalian vulva—rectum cancer	0.0175	0.0224	CbGeAlD
Mitoxantrone—PIM1—lymph node—rectum cancer	0.0164	0.021	CbGeAlD
Mitoxantrone—ABCC1—seminal vesicle—rectum cancer	0.0153	0.0196	CbGeAlD
Mitoxantrone—SLC47A2—SLC-mediated transmembrane transport—SLC14A2—rectum cancer	0.0152	0.069	CbGpPWpGaD
Mitoxantrone—SLC47A1—female reproductive system—rectum cancer	0.015	0.0192	CbGeAlD
Mitoxantrone—TOP2A—vagina—rectum cancer	0.0148	0.019	CbGeAlD
Mitoxantrone—CYP1B1—smooth muscle tissue—rectum cancer	0.0143	0.0183	CbGeAlD
Mitoxantrone—CYP1B1—renal system—rectum cancer	0.0137	0.0176	CbGeAlD
Mitoxantrone—SLC47A1—vagina—rectum cancer	0.0136	0.0174	CbGeAlD
Mitoxantrone—ABCG2—seminal vesicle—rectum cancer	0.0127	0.0163	CbGeAlD
Mitoxantrone—ABCC1—urethra—rectum cancer	0.0121	0.0155	CbGeAlD
Mitoxantrone—ABCC1—mammalian vulva—rectum cancer	0.0115	0.0148	CbGeAlD
Mitoxantrone—CYP1B1—female reproductive system—rectum cancer	0.011	0.0141	CbGeAlD
Mitoxantrone—CYP2E1—seminal vesicle—rectum cancer	0.011	0.0141	CbGeAlD
Mitoxantrone—ABCG2—urethra—rectum cancer	0.01	0.0129	CbGeAlD
Mitoxantrone—SLC47A1—SLC-mediated transmembrane transport—SLC14A2—rectum cancer	0.00978	0.0445	CbGpPWpGaD
Mitoxantrone—TOP2A—lymph node—rectum cancer	0.0096	0.0123	CbGeAlD
Mitoxantrone—ABCG2—mammalian vulva—rectum cancer	0.00955	0.0122	CbGeAlD
Mitoxantrone—ABCC1—vagina—rectum cancer	0.00894	0.0115	CbGeAlD
Mitoxantrone—CYP2E1—renal system—rectum cancer	0.00885	0.0113	CbGeAlD
Mitoxantrone—SLC47A1—lymph node—rectum cancer	0.00877	0.0112	CbGeAlD
Mitoxantrone—CYP2E1—urethra—rectum cancer	0.00869	0.0111	CbGeAlD
Mitoxantrone—PIM1—GMCSF-mediated signaling events—NRAS—rectum cancer	0.00857	0.039	CbGpPWpGaD
Mitoxantrone—SLC47A2—Transmembrane transport of small molecules—SLC14A2—rectum cancer	0.00771	0.0351	CbGpPWpGaD
Mitoxantrone—ABCG2—vagina—rectum cancer	0.0074	0.00949	CbGeAlD
Mitoxantrone—PIM1—GMCSF-mediated signaling events—KRAS—rectum cancer	0.00737	0.0335	CbGpPWpGaD
Mitoxantrone—CYP3A4—renal system—rectum cancer	0.00712	0.00912	CbGeAlD
Mitoxantrone—CYP2E1—female reproductive system—rectum cancer	0.00708	0.00908	CbGeAlD
Mitoxantrone—CYP1B1—lymph node—rectum cancer	0.00643	0.00824	CbGeAlD
Mitoxantrone—PIM1—GMCSF-mediated signaling events—HRAS—rectum cancer	0.00627	0.0285	CbGpPWpGaD
Mitoxantrone—ABCB1—seminal vesicle—rectum cancer	0.00625	0.00801	CbGeAlD
Mitoxantrone—ABCC1—lymph node—rectum cancer	0.00578	0.00741	CbGeAlD
Mitoxantrone—ABCG2—Fluoropyrimidine Activity—SMUG1—rectum cancer	0.00577	0.0263	CbGpPWpGaD
Mitoxantrone—CYP3A4—female reproductive system—rectum cancer	0.0057	0.00731	CbGeAlD
Mitoxantrone—ABCB1—epithelium—rectum cancer	0.00543	0.00696	CbGeAlD
Mitoxantrone—ABCB1—renal system—rectum cancer	0.00504	0.00646	CbGeAlD
Mitoxantrone—SLC47A1—Transmembrane transport of small molecules—SLC14A2—rectum cancer	0.00497	0.0226	CbGpPWpGaD
Mitoxantrone—ABCB1—urethra—rectum cancer	0.00495	0.00634	CbGeAlD
Mitoxantrone—ABCG2—lymph node—rectum cancer	0.00479	0.00614	CbGeAlD
Mitoxantrone—ABCB1—mammalian vulva—rectum cancer	0.00471	0.00604	CbGeAlD
Mitoxantrone—ABCG2—Fluoropyrimidine Activity—TYMS—rectum cancer	0.00462	0.021	CbGpPWpGaD
Mitoxantrone—PIM1—C-MYB transcription factor network—NRAS—rectum cancer	0.00445	0.0202	CbGpPWpGaD
Mitoxantrone—ABCB1—female reproductive system—rectum cancer	0.00403	0.00517	CbGeAlD
Mitoxantrone—BTK—Class I PI3K signaling events—NRAS—rectum cancer	0.00395	0.018	CbGpPWpGaD
Mitoxantrone—PIM1—C-MYB transcription factor network—KRAS—rectum cancer	0.00383	0.0174	CbGpPWpGaD
Mitoxantrone—BTK—EPO signaling pathway—HRAS—rectum cancer	0.0038	0.0173	CbGpPWpGaD
Mitoxantrone—BTK—IL-5 Signaling Pathway—KRAS—rectum cancer	0.00373	0.017	CbGpPWpGaD
Mitoxantrone—ABCB1—vagina—rectum cancer	0.00365	0.00468	CbGeAlD
Mitoxantrone—PIM1—Validated targets of C-MYC transcriptional activation—TP53—rectum cancer	0.00357	0.0162	CbGpPWpGaD
Mitoxantrone—TOP2A—Retinoblastoma (RB) in Cancer—TYMS—rectum cancer	0.0035	0.0159	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle, Mitotic—RAB1A—rectum cancer	0.00348	0.0158	CbGpPWpGaD
Mitoxantrone—BTK—Class I PI3K signaling events—KRAS—rectum cancer	0.0034	0.0155	CbGpPWpGaD
Mitoxantrone—PIM1—C-MYB transcription factor network—HRAS—rectum cancer	0.00325	0.0148	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle—RAB1A—rectum cancer	0.00311	0.0141	CbGpPWpGaD
Mitoxantrone—BTK—Class I PI3K signaling events—HRAS—rectum cancer	0.00289	0.0131	CbGpPWpGaD
Mitoxantrone—TOP2A—Gastric Cancer Network 2—TP53—rectum cancer	0.00265	0.012	CbGpPWpGaD
Mitoxantrone—TOP2A—Mitotic G1-G1/S phases—TYMS—rectum cancer	0.00246	0.0112	CbGpPWpGaD
Mitoxantrone—ABCB1—lymph node—rectum cancer	0.00236	0.00303	CbGeAlD
Mitoxantrone—BTK—Kit receptor signaling pathway—HRAS—rectum cancer	0.00233	0.0106	CbGpPWpGaD
Mitoxantrone—BTK—Fc-epsilon receptor I signaling in mast cells—HRAS—rectum cancer	0.00227	0.0103	CbGpPWpGaD
Mitoxantrone—BTK—BCR signaling pathway—HRAS—rectum cancer	0.0021	0.00956	CbGpPWpGaD
Mitoxantrone—ABCC1—Transmembrane transport of small molecules—SLC14A2—rectum cancer	0.00187	0.00851	CbGpPWpGaD
Mitoxantrone—TOP2A—Integrated Pancreatic Cancer Pathway—TYMS—rectum cancer	0.00186	0.00847	CbGpPWpGaD
Mitoxantrone—TOP2A—Circadian rythm related genes—TYMS—rectum cancer	0.00179	0.00813	CbGpPWpGaD
Mitoxantrone—CYP1B1—Aryl Hydrocarbon Receptor—NRAS—rectum cancer	0.00169	0.00768	CbGpPWpGaD
Mitoxantrone—ABCG2—Transmembrane transport of small molecules—SLC14A2—rectum cancer	0.00165	0.00748	CbGpPWpGaD
Mitoxantrone—BTK—B Cell Receptor Signaling Pathway—HRAS—rectum cancer	0.00156	0.00711	CbGpPWpGaD
Mitoxantrone—ABCG2—Fluoropyrimidine Activity—TP53—rectum cancer	0.00153	0.00697	CbGpPWpGaD
Mitoxantrone—CYP1B1—Aryl Hydrocarbon Receptor—KRAS—rectum cancer	0.00145	0.00661	CbGpPWpGaD
Mitoxantrone—BTK—DAP12 signaling—NRAS—rectum cancer	0.0014	0.00638	CbGpPWpGaD
Mitoxantrone—BTK—Fc epsilon receptor (FCERI) signaling—NRAS—rectum cancer	0.00132	0.00601	CbGpPWpGaD
Mitoxantrone—BTK—DAP12 interactions—NRAS—rectum cancer	0.00132	0.00601	CbGpPWpGaD
Mitoxantrone—CYP1B1—Aryl Hydrocarbon Receptor—HRAS—rectum cancer	0.00124	0.00562	CbGpPWpGaD
Mitoxantrone—BTK—B Cell Activation—NRAS—rectum cancer	0.00122	0.00556	CbGpPWpGaD
Mitoxantrone—BTK—DAP12 signaling—KRAS—rectum cancer	0.00121	0.00549	CbGpPWpGaD
Mitoxantrone—TOP2A—Retinoblastoma (RB) in Cancer—TP53—rectum cancer	0.00116	0.00527	CbGpPWpGaD
Mitoxantrone—BTK—Fc epsilon receptor (FCERI) signaling—KRAS—rectum cancer	0.00114	0.00517	CbGpPWpGaD
Mitoxantrone—BTK—DAP12 interactions—KRAS—rectum cancer	0.00114	0.00517	CbGpPWpGaD
Mitoxantrone—BTK—B Cell Activation—KRAS—rectum cancer	0.00105	0.00478	CbGpPWpGaD
Mitoxantrone—BTK—DAP12 signaling—HRAS—rectum cancer	0.00103	0.00467	CbGpPWpGaD
Mitoxantrone—BTK—DAP12 interactions—HRAS—rectum cancer	0.000966	0.00439	CbGpPWpGaD
Mitoxantrone—BTK—Fc epsilon receptor (FCERI) signaling—HRAS—rectum cancer	0.000966	0.00439	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle, Mitotic—TYMS—rectum cancer	0.000902	0.0041	CbGpPWpGaD
Mitoxantrone—BTK—B Cell Activation—HRAS—rectum cancer	0.000894	0.00407	CbGpPWpGaD
Mitoxantrone—ABCB1—Transmembrane transport of small molecules—SLC14A2—rectum cancer	0.00089	0.00405	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle—TYMS—rectum cancer	0.000806	0.00367	CbGpPWpGaD
Mitoxantrone—TOP2A—Integrated Pancreatic Cancer Pathway—KRAS—rectum cancer	0.000695	0.00316	CbGpPWpGaD
Mitoxantrone—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—rectum cancer	0.000618	0.00281	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—rectum cancer	0.000613	0.00279	CbGpPWpGaD
Mitoxantrone—TOP2A—Circadian rythm related genes—TP53—rectum cancer	0.000593	0.0027	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—NRAS—rectum cancer	0.000513	0.00233	CbGpPWpGaD
Mitoxantrone—BTK—Adaptive Immune System—NRAS—rectum cancer	0.000493	0.00224	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—KRAS—rectum cancer	0.000442	0.00201	CbGpPWpGaD
Mitoxantrone—BTK—Adaptive Immune System—KRAS—rectum cancer	0.000424	0.00193	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—HRAS—rectum cancer	0.000375	0.00171	CbGpPWpGaD
Mitoxantrone—BTK—Adaptive Immune System—HRAS—rectum cancer	0.00036	0.00164	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—NRAS—rectum cancer	0.000299	0.00136	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle—TP53—rectum cancer	0.000267	0.00122	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—KRAS—rectum cancer	0.000257	0.00117	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—TYMS—rectum cancer	0.00024	0.00109	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—TYMS—rectum cancer	0.000232	0.00105	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—rectum cancer	0.000229	0.00104	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—HRAS—rectum cancer	0.000219	0.000994	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—TYMS—rectum cancer	0.000211	0.00096	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—rectum cancer	0.000203	0.000925	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—TYMS—rectum cancer	0.000152	0.000689	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—NRAS—rectum cancer	0.000124	0.000565	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—TYMS—rectum cancer	0.000114	0.000519	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—KRAS—rectum cancer	0.000107	0.000486	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—HRAS—rectum cancer	9.08e-05	0.000413	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—TYMS—rectum cancer	7.03e-05	0.00032	CbGpPWpGaD
